STENOCARE A/S on track with the planned offering of Medical Cannabis Capsules to offer Danish patients more choice in their treatment
On November 9, 2018, STENOCARE A/S (“STENOCARE”) announced its plan to expand the product portfolio with three medical cannabis capsule products. Today the company announces that the formal application for the approval of the three new products have been submitted to the Danish Medicine Agency. The capsule product is a new category that will offer the patients an optional dosage form in their treatment with medical cannabis. STENOCARE hope to be ready with the first shipment during late Summer 2019.STENOCARE has since September 2018 delivered three different medical cannabis oil products to